Literature DB >> 34272655

Altered Expression of miR-575 in Glioma is Related to Tumor Cell Proliferation, Migration, and Invasion.

Guangxin Wei1, Shengjun Li1, Pengcheng Wang1, Shouxian Wang1, Yujing Zhao2.   

Abstract

Glioma is a kind of brain tumor with low overall survival and treatment success rates in the advanced stage. Evidence has shown microRNA-575 (miR-575) plays an important role in the generation and development of various cancers. This study aimed to explore the function of miR-575 in the prognosis and cell biological behavior of glioma. qRT-PCR was used to evaluate the expression of miR-575 in glioma tissues and cells, Kaplan-Meier survival analysis and Cox regression analysis were used to evaluate the prognostic value. The proliferation ability of glioma cells was determined by MTT assay; the invasion and migration abilities were determined by transwell assays. Compared with normal brain tissues, the expression of miR-575 in glioma tissue cells was significantly up-regulated (P < 0.001). The survival rate of patients in the miR-575 high expression group was significantly lower than that in the low expression group (P = 0.020). In addition, the overexpression of miR-575 promoted the proliferation, migration, and invasion of glioma cells. The results of this study suggested that miR-575 may be a new biomarker for the prognosis of glioma.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Glioma; Invasion; Migration; Prognosis; Proliferation; microRNA-575

Mesh:

Substances:

Year:  2021        PMID: 34272655     DOI: 10.1007/s12017-021-08679-7

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  30 in total

Review 1.  The role of microRNAs in prostate cancer migration, invasion, and metastasis.

Authors:  Shirin Golabi Aghdam; Mehrdad Ebrazeh; Maryam Hemmatzadeh; Narges Seyfizadeh; Arezoo Gowhari Shabgah; Gholamreza Azizi; Negin Ebrahimi; Farhad Babaie; Hamed Mohammadi
Journal:  J Cell Physiol       Date:  2018-12-07       Impact factor: 6.384

Review 2.  miRNA assays in the clinical laboratory: workflow, detection technologies and automation aspects.

Authors:  Andreas Kappel; Andreas Keller
Journal:  Clin Chem Lab Med       Date:  2017-05-01       Impact factor: 3.694

Review 3.  Primary brain tumours in adults.

Authors:  Sarah Lapointe; Arie Perry; Nicholas A Butowski
Journal:  Lancet       Date:  2018-07-27       Impact factor: 79.321

4.  An improvement of miRNA extraction efficiency in human plasma.

Authors:  Eunmi Ban; Dong-Kyu Chae; Young Sook Yoo; Eun Joo Song
Journal:  Anal Bioanal Chem       Date:  2017-08-25       Impact factor: 4.142

Review 5.  Glioma Subclassifications and Their Clinical Significance.

Authors:  Ricky Chen; Matthew Smith-Cohn; Adam L Cohen; Howard Colman
Journal:  Neurotherapeutics       Date:  2017-04       Impact factor: 7.620

Review 6.  Further understanding of the pathology of glioma: implications for the clinic.

Authors:  Sandra Camelo-Piragua; Santosh Kesari
Journal:  Expert Rev Neurother       Date:  2016-06-16       Impact factor: 4.618

7.  MicroRNA-599 suppresses glioma progression by targeting RAB27B.

Authors:  Yu Jiang; Xiaohui Wang; Ji Zhang; Renchun Lai
Journal:  Oncol Lett       Date:  2018-05-16       Impact factor: 2.967

8.  On the origin of glioma.

Authors:  Yiwen Jiang; Lene Uhrbom
Journal:  Ups J Med Sci       Date:  2012-02-21       Impact factor: 2.384

Review 9.  MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma.

Authors:  C Nelson Hayes; Kazuaki Chayama
Journal:  Int J Mol Sci       Date:  2016-02-24       Impact factor: 5.923

10.  Elevated CD44 expression predicts poor prognosis in patients with low-grade glioma.

Authors:  Qiang Dong; Qiao Li; Maolin Wang; Jianhong Hu; Junqiang Dai; Liang Niu; Guoqiang Yuan; Yawen Pan
Journal:  Oncol Lett       Date:  2019-08-07       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.